Monoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent Lymphoma
Ontology highlight
ABSTRACT: RATIONALE: Monoclonal antibodies can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.
PURPOSE: Phase I trial to study the effectiveness of monoclonal antibody therapy in treating patients who have advanced or recurrent lymphoma.
DISEASE(S): Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms
PROVIDER: 2005072 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA